SIA
SYNH

Strategic Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Strategic Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,122
Closed -$1.04M – 211
2021
Q4 		$1.04M Buy
10,122
+9
+0.1% +$864 0.2% 103
2021
Q3 		$885K Buy
+10,113
New +$915K 0.19% 110

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Strategic Investment Advisors's SYNH Position: Q1 2022 in Review

Strategic Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 10,122 shares — an estimated $1.04M sold.

Strategic Investment Advisors first reported a position in SYNH in Q3 2021 and held it in 2 quarters. The position peaked at $1.04M in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Strategic Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Strategic Investment Advisors sold 10,122 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.04M.
  • Strategic Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 2 quarters.
  • Strategic Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1.04M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Strategic Investment Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.